A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)
Clinical trial NCT04605991 · COMPLETED
Trial details
- NCT number
- NCT04605991
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-04
- Primary completion
- 2022-02-04
- Enrollment
- 187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.